Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: CD34
Name: CD34 molecule
Location: 01q32.2
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT00005783 A Phase III Trial of Recombinant-Methionyl Human Stem Cell Factor SCF in Adult Patients With Sickling Disorders View
NCT00007813 Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors View
NCT00001507 Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer View
NCT00003398 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer View
NCT00001255 Gene Transfer Therapy for Severe Combined Immunodeficieny Disease SCID Due to Adenosine Deaminase ADA Deficiency A Natural History Study View
NCT00018018 Gene Transfer Therapy for Severe Combined Immunodeficieny Disease SCID Due to Adenosine Deaminase ADA Deficiency View
NCT00017641 Phase I Study of Immune Ablation and CD34 Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus View
NCT00021801 Islet Cell Transplantation Alone and CD34 Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus Steroid-Free Regimen View
NCT00075335 AMD 3100 Mozobil Plerixafor to Mobilize Stem Cells for Donation View
NCT00086476 Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles View
NCT00085449 Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine Mycophenolate Mofetil and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer View
NCT00092937 Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant View
NCT00186823 Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies View
NCT00197522 Administration of Autologous Dendritic Cells DCs Infected With an Adenovirus Expressing Her-2 View
NCT00201240 Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia BMT CTN 0303 View
NCT00244010 Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias View
NCT00279539 Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure View
NCT00313339 Intra-coronary Infusion of Bone Marrow Derived Autologous CD34 Selected Cells in Patients With Acute Myocardial Infarction View
NCT00314106 Chemotherapy Irradiation Cell Infusions and Interleukin-2 to Treat Metastatic Melanoma View
NCT00394316 Gene Therapy for Chronic Granulomatous Disease View
NCT03081754 Correlation of Uterine and Umbilical Arteries Doppler With Placental Pathology in IUGR View
NCT02800070 Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease View
NCT00604201 Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome View
NCT00722254 Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder View
NCT00731744 Generation of Dendritic Cell Precursors From Cord Blood Stem Cells View
NCT00968864 T-cell Depleted Alternative Donor Transplantation View
NCT00767260 Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus View
NCT02061800 CD34 Malignant Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant View
NCT00794508 MND-ADA Transduction of CD34 Cells From Children With ADA-SCID View
NCT00819143 Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease View
NCT00871702 Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease View
NCT01560182 Gene Therapy for Metachromatic Leukodystrophy MLD View
NCT01105403 Exploratory Study on POL6326 in Stem Cell Mobilization View
NCT01095757 Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection View
NCT01174108 Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34 Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells View
NCT01200017 Expanded Access Protocol EAP Using the CliniMACS Device for Pediatric Haplocompatible Donor Stem Cell Transplant View
NCT01215487 A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib View
NCT01350310 Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy View
NCT01379391 Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT View
NCT00820586 Intramyocardial Delivery of Autologous Bone Marrow View
NCT00004232 Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer View
NCT01462396 Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors View
NCT01686269 Endothelial Progenitor Cells View
NCT00006314 Cytomegalovirus Spread and Reactivation in Blood Cells View
NCT01950585 Hydroxyurea in Pulmonary Arterial Hypertension View
NCT02015013 Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models View
NCT04248439 Gene Therapy for Fanconi Anemia Complementation Group A View
NCT02038478 Allograft for Sickle Cell Disease and Thalassemia View
NCT00993486 Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related Haploidentical Donor View
NCT02234934 Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease View
NCT02439476 Non-interventional Study on Salvage Auto in Relapsed Myeloma View
NCT02451033 Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver An Open Label Study View
NCT01466335 An Adaptive Phase I Study to Evaluate the Safety Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers View
NCT00004904 Stem Cell Transplantation in Treating Patients With Hematologic Cancer View
NCT06107322 Hematological Effects of Atypical Antipsychotics AAPs in a Geriatric Population What is the Role of 5-HT2 Receptors View
NCT00569179 A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies View
NCT00062543 Hepatic Artery Infusion of CD34 Cells View
NCT02797470 Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant View
NCT00265837 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer View
NCT02842112 Higher Percentage of CD34 CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia View
NCT00112567 Total-Body Irradiation Thiotepa and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer View
NCT02989701 Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell HSC Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell HSC Mobilization in Patients With Sickle Cell Disease View
NCT03107273 Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes View
NCT06465160 A Study to Evaluate the MNV-201 in Patients With Low Risk MDS View
NCT05207657 Lentiviral Gene Therapy for p47 AR-CGD View
NCT01036009 A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies View
NCT03837483 A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome View
NCT03907553 Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly View
NCT03911037 GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT View
NCT04126603 Impact of Semaglutide on CD34 EPC and Fat Derived MSC View
NCT00761982 Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment View
NCT02687672 Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury View
NCT04282174 CD34 Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies View
NCT04283227 OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy MLD View
NCT04806347 AlphaBeta T-cell Depleted Blood-forming Stem Cell Transplant from Related or Unrelated Donors for Blood Diseases in Children and Young Adults View
NCT00322127 An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34 Cells in Healthy Volunteers View
NCT06422351 Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency View
NCT00185692 Allogeneic Transplantation From Related Haploidentical Donors View
NCT00322491 Mobilization of Stem Cells With AMD3100 Plerixafor and G-CSF in Non-Hodgkins Lymphoma and Multiple Myeloma Patients View
NCT01212055 Apheresis of Patients With Immunodeficiency View
NCT05760326 Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients View
NCT00396383 Treatment With AMD3100 Plerixafor in MM Patients to Mobilize PBCs For Collection and for Transplantation View
NCT00391833 Effect of Panax Ginseng on the Cognitive Performance in Alzheimers Disease View
NCT06253507 pCCLCHIM-p47 Lentiviral Vector Transduced CD34 Plus Cells in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease AR-CGD View
NCT01119066 HLA-Compatible Related or Unrelated Donors With CD34 Enriched T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies View
NCT01100840 A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer View
NCT04243681 Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis View
NCT05385705 A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer NK-ACT-BC_2020 View
NCT02467478 Linagliptins Effect on CD34 Stem Cells View
NCT01165762 Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs View
NCT00432419 Therapeutic Intensification of HIV-associated Non-Hodgkins Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy View
NCT00444912 The Effect of Rituximab on Mobilization With AMD3100 Plerixafor Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma NHL or Hodgkin Disease HD View
NCT00858793 High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT View
NCT00460629 Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation View
NCT00001476 Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up View
NCT00466674 Treatment of Myeloma in Patients 65 Years Old With Response 50 After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning View
NCT00001750 Comparing Treatments for Multiple Myeloma View
NCT01660347 Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant View
NCT00074997 An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 CD34 Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 HIV-1 Ribozyme OZ1 in Participants With HIV-1 Infection View
NCT01700608 Prospective Observational Study on Plerixafor After Chemotherapy View
NCT01277549 Evaluation of the Spectra Optia Apheresis System Mononuclear Cell MNC Collection Procedure in Healthy Blood Donors View
NCT00096382 Cyclophosphamide Fludarabine and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy Autologous Stem Cell Transplantation and Interleukin-2 in Treating Patients With Metastatic Melanoma View
NCT01286675 Effect of Eltrombopag Plus G-CSF on Human CD34 Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT View
NCT00002718 T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia Lymphoblastic Lymphoma Myelodysplastic Syndrome or Aplastic Anemia View
NCT01300793 Study of Standard-Dose Rituximab Ifosfamide Carboplatin and Etoposide View
NCT00147043 Adult Stem Cell Therapy in Liver Insufficiency View
NCT00422890 Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine Vidaza View
NCT00315614 Islet Cell Transplantation Alone and CD34 Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus View
NCT00346177 Stem Cell Study for Patients With Heart Failure View
NCT00396201 AMD3100 Plerixafor Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor G-CSF to Increase the Number of Peripheral Blood Stem Cells PBSCs in Patients With Hodgkins Disease View
NCT00429416 Research Study to Determine if an Experimental Agent LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease GVHD Following Blood Hematopoietic Stem Cell Transplantation View
NCT04437771 Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy View
NCT00535197 Autologous Bone Marrow Stem Cells in Ischemic Stroke View
NCT00535912 Phase III Study Treatment of CLL B and C View
NCT00545610 ACT34-CMI -- Adult Autologous CD34 Stem Cells Follow-Up Study View
NCT01504594 Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy View
NCT00564759 Gene Therapy for Chronic Granulomatous Disease View
NCT01801371 68Ga-BNOTA-PRGD2 PETCT in Diagnosis and Evaluation of Glioma View
NCT04489420 Natural Killer Cell CYNK-001 IV Infusion or IT Administration in Adults With Recurrent GBM View
NCT01508910 Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34 Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina View
NCT00593554 Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies View
NCT00616980 Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia View
NCT00620048 Stem Cell Study for Subjects With Congestive Heart Failure View
NCT00103610 Mobilization of Stem Cells With AMD3100 Plerixafor in Non-Hodgkins Lymphoma Patients View
NCT01555359 Telomerase Activity as a Marker For Mobilization Quality View
NCT04525352 A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis View
NCT00669305 Bone Marrow for Hemoglobinopathy Research View
NCT01954914 Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers View
NCT04522817 CLBS119 for Repair of COVID-19 Induced Pulmonary Damage View
NCT00695370 Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children View
NCT00722098 Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients View
NCT01598025 Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor View
NCT00741325 Long-Term Follow-up Study for Non-Hodgkins Lymphoma Patients Who Received Study Treatment Plerixafor or Placebo in the AMD3100-3101 Study NCT00103610 View
NCT00741780 Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment Plerixafor or Placebo in the AMD3100-3102 Study NCT00103662 View
NCT01591109 A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF Therapy View
NCT00751894 Pegfilgrastim for Stem Cell Mobilization in Children Meg-5 View
NCT04567563 Remote Ischemic Conditioning and Diabetic Foot Ulcers View
NCT01639690 ß-Thalassemia Major with Autologous CD34 Hematopoietic Progenitor Cells Transduced with TNS9355 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene View
NCT00002788 High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia View
NCT04614467 A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction View
NCT02056210 Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects View
NCT00927134 Gene Therapy for X-linked Chronic Granulomatous Disease CGD in Children View
NCT02709876 Autologous Bone Marrow-Derived CD34 CD133 and CD271 Stem Cell Transplantation for Retinitis Pigmentosa View
NCT00950521 Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients View
NCT02221479 Plerixafor Plus Granulocyte Colony-stimulating Factor G-CSF For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma View
NCT02221492 Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma View
NCT01026987 Granulocyte Colony-stimulating Factor G-CSF Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant View
NCT02820207 Identification of Carotid Plague Vulnerability by Contrast Enhanced Ultrasound Correlation With Plague Histopathology View
NCT02646098 CD34 Selected ASCT for Aggressive Lymphomas View
NCT01693952 Sepsis in Neutropenic Patients Autologous Stem Cell Transplantation as Model a Transcriptomic Approach View
NCT01049854 CD34Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant View
NCT04678401 IS-free Treg HaploHCT View
NCT00476294 Long-Term Follow Up Study for AMD3100 Patients View
NCT00473551 Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies View
NCT02127892 SCID BuFluATG Study With T Cell Depletion View
NCT01716793 Risk-adapted Therapy for Adult Acute Myeloid Leukemia View
NCT01728545 The Collection and Storage of Umbilical Cord Blood for Transplantation View
NCT01149863 Alteration in Timing of Plerixafor Administration View
NCT01164475 Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkins Lymphoma NHL Weighing Less Than 70 Kilograms View
NCT01512888 Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants View
NCT01177059 Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 HIV-1 Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial View
NCT01189786 Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection View
NCT02557191 Biomarkers Neurodevelopment and Preterm Infants View
NCT01736059 Clinical Trial of Autologous Intravitreal Bone-marrow CD34 Stem Cells for Retinopathy View
NCT00005796 Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors View
NCT02151526 A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major Also Referred to as Transfusion-dependent β-Thalassemia TDT and Sickle Cell Disease View
NCT01734850 Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection View
NCT02641769 Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility View
NCT04091737 CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease View
NCT02165007 Haploidentical Hematopoietic Stem Cell Transplantation View
NCT01745120 A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants View
NCT01506258 Autologous Stem Cells in Newborns With Oxygen Deprivation View
NCT04797260 Phase III Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID View
NCT04804891 Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation View
NCT02915406 cliniMACs HUD for T Cell Depletion View
NCT01765803 Feasibility of Thioridazine as a Mobilizing Agent for CD34 Hematopoietic Progenitor Cells View
NCT04817345 Peripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease SCD Using Plerixafor View
NCT02390297 Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients View
NCT01411904 A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia View
NCT02500849 Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stemprogenitor Cells in HIV-1 Infected Patients View
NCT01802892 Study in Healthy Volunteers to Evaluate the Safety Efficacy and Dose Responses of SB-751689 Ronacaleret View
NCT01794299 Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells ATIR in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor View
NCT04872595 A Modified Dose of Rabbit Anti-thymocyte Globulin rATG in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant View
NCT01495364 NBS10 Also Known as AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction View
NCT03029000 Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants View
NCT03134027 Reconstitution of a Human Immune System in a Patient Derived Xenograft PDX Model of Genitourinary GU Cancers View
NCT01596257 Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation View
NCT01615250 Implantation of Peripheral Stem Cells in Patient With Ischemic Cardiomyopathy View
NCT04982354 Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia View
NCT02999984 Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID View
NCT05086003 Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction View
NCT01767714 Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5106CD34 Cellskg in Non-Hodgkins Lymphoma NHL Patients for Autologous Transplantation View
NCT03130582 High-dose Etoposide Could Discriminate Patients With RefractoryRelapsed Lymphoma Benefit From APBSCT View
NCT03311503 Phase III Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning View
NCT01856582 CD34 Stem Cell Infusion to Augment Graft Function View
NCT03157804 Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A View
NCT02023814 Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest View
NCT02026934 CliniMACS CD34 Reagent System for Expanded Access Use View
NCT02089828 Purified CD34 Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia View
NCT03384420 A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome View
NCT03392987 A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy MLD View
NCT02162511 CD34 Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function View
NCT02193191 Escalation of Plerixafor for Mobilization of CD34 Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease View
NCT02247843 Stem Cell Gene Therapy for Sickle Cell Disease View
NCT05456880 BEACON A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease View
NCT02258490 Expanded Use of G-CSF Mobilized Donor CD34 Selected Cells for Allogeneic Transplantation View
NCT05485467 The Role of CD34 Stem Cells and Biomarkers in the Development of CAV in HTX Patients View
NCT03630211 Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis View
NCT02788240 To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase View
NCT02333760 Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome View
NCT04151706 CD34 Selected Allogeneic HCT w Myeloablative Conditioning Plus CD8 Memory TCell Infusion in MDS AL and CML View
NCT02370888 Lenalidomide After Allo-Hematopoietic Cell Transplant HCT in Acute Myelogenous Leukemia AML and Myelodysplastic Syndromes MDS Subjects With Minimal Residual Disease View
NCT00010335 Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide Anti-thymocyte Globulin and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders View
NCT05577312 Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia View
NCT01810588 Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation View
NCT02454231 Monocentric Trial Stem Cell Emergency Life Threatening Limbs Arteriopathy SCELTA View
NCT05617625 CD34 Enriched Transplants to Treat Myelodysplastic Syndrome View
NCT05618301 Motixafortide and Natalizumab to Mobilize CD34 Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease SCD View
NCT03731611 Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency View
NCT05665166 Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type II View
NCT02589301 Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations View
NCT03591302 Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs View
NCT03600909 A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia View
NCT04201405 Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type IIIA View
NCT03606746 Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch Living Donor Kidney Transplants View
NCT02669810 EXCELLENT EXpanded CELL ENdocardiac Transplantation View
NCT05757245 A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants View
NCT05762510 A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia TDT View
NCT05773729 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia View
NCT05776173 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia View
NCT03866109 A Study Evaluating Temferon in Patients With Glioblastoma Unmethylated MGMT View
NCT02919709 Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells View
NCT02923609 Cell Therapy in HFpEF View
NCT04310592 Natural Killer Cell CYNK-001 Infusions in Adults With AML View
NCT05922384 Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma View
NCT05968170 TCRαβCD19 Depletion of Stem Cell Grafts for Transplant View
NCT03098771 Peripheral Blood Autologous CD34 Cell Transplantation Promotes Angiogenesis With Atherosclerotic Ischemia for Elderly View
NCT03093844 Haploidentical CD34 Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders View
NCT03134456 Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX View
NCT03164135 Safety of Transplantation of CRISPR CCR5 Modified CD34 Cells in HIV-infected Subjects With Hematological Malignances View
NCT03207009 A Study Evaluating the Efficacy and Safety of the LentiGlobin BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia View
NCT05536154 EtoposideCytarabinePEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies View
NCT03244930 Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation View
NCT04774536 Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells CRISPR_SCD001 in Patients with Severe Sickle Cell Disease View
NCT03363945 Cellular Immunotherapy in Recipients of HLA-matched Living Donor Kidney Transplants View
NCT06154044 Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support View
NCT03376503 Nanogen Pegfilgrastim Pegcyte PKPD Clinical Study in Breast Cancer Patients View
NCT03471611 Study of Intracoronary CD34 Cell Administration in Patients With Early Coronary Atherosclerosis View
NCT03483324 Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation View
NCT03508609 Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease View
NCT03517631 An Efficacy and Safety Study of shRNA-modified CD34 Cells in HIV-infected Patients View
NCT03593187 A Study Evaluating the Safety of Cal-1 LVsh5C46 Drug Product in HIV-1 Infected Patient With High Risk Lymphoma View
NCT04853576 A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease RUBY View
NCT03664830 Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease View
NCT05290662 Registry of Patients Having Received oNKord View
NCT03745287 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease View
NCT04878835 Effects of Ranibizumab in Primary Pterygium Surgery View
NCT00551928 Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients View
NCT05093725 CD49 in Optimization The Cologenicity of Mesenchymal Stem Cell Culture Passage View
NCT06465550 A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell BD211 Treating β-thalassemia Major View
NCT04990427 CLBS201 in Patients with Chronic Kidney Disease CKD and Type 2 Diabetes Mellitus T2DM View
NCT03964792 Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34 Enriched Cell Fraction That Contains CD34 Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease DREPAGLOBE View
NCT03981549 Treatment of Central Retinal Vein Occlusion Using Stem Cells Study View
NCT03983902 Placental Transfusion Methods and Stem Cells View
NCT02860793 Role of PTK-7 in Acute Myeloid Leukemias View
NCT04069533 Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A View
NCT01855685 Gene Therapy for X-linked Chronic Granulomatous Disease X-CGD View
NCT04105166 Gene Therapy for Pyruvate Kinase Deficiency PKD View
NCT01852071 Autologous CD34 Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened EFS Lentiviral Vector Encoding for the Human ADA Gene View
NCT04143568 Circulating Progenitor Cells Levels in Periodontal Disease Patients View
NCT05207722 CYNK-101 in Combination With Trastuzumab and Pembrolizumab in Patients With Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction GGEJ Adenocarcinoma View
NCT05071222 Safety and Efficacy Study of Transplantation of Autologous CD34 Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis DCLRE1C Deficient Severe Combined Immunodeficiency Patients ARTEGENE View
NCT04198883 SINGaporean Program Performed With an eXPANsion Medical Device SingXpand View
NCT04214886 CD19 Chimeric Antigen Receptor CAR T Cells for Adults With Recurrent or Refractory B Cell Malignancies View
NCT05702853 Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19 RelapsedRefractory NHL CLLSLL View
NCT04293185 A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease View
NCT04309084 Natural Killer Cell CYNK-001 Infusions in Adults With Multiple Myeloma View
NCT00911339 Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents View
NCT04365101 Natural Killer Cell CYNK-001 Infusions in Adults With COVID-19 View
NCT04418414 Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A View
NCT01866839 Preventing Stem Cell Transplant Complications With a Blood Separator Machine View
NCT06017869 Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-201 in Pediatric Patients With Pearson Syndrome View
NCT04548843 A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC Autologous CD34 Cells Enriched With Placenta Derived Allogeneic Mitochondria in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion View
NCT04587856 Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients View
NCT04635384 Assessment of Chimerism and Relapse Post Bone MarrowHematopoietic Cell Transplant HCT Using AlloHeme Test View
NCT04635735 Study of Ipilimumab After Stem Cell Transplantation in People With RelapsedRefractory Multiple Myeloma View
NCT05970185 The Value of Peripheral Blood CD34 Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization View
NCT04819841 Gene Correction in Autologous CD34 Hematopoietic Stem Cells HbS to HbA to Treat Severe Sickle Cell Disease View
NCT06082947 αβT CellCD19 B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation HSCT View
NCT04925206 A Safety and Efficacy Study Evaluating ET-01 in Subjects With Transfusion Dependent β-Thalassaemia View
NCT04925687 Phase 1 Study of Intravitreal Autologous CD34 Stem Cell Therapy for Retinitis Pigmentosa View
NCT06300723 Clinical Study of BRL-101 in Severe SCD View
NCT01896102 A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy CALD View
NCT05329649 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease SCD View
NCT06649227 Study Investigating the Safety of CD19 CAR-T Cells in RelapsedRefractory AML Expressing CD19 View
NCT06547112 A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide G-CSF Mobilization View
NCT05356195 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia TDT View
NCT01906541 Gene Therapy for X-CGD View
NCT02931071 Clinical Phase II Trial to Evaluate CD34 Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene FANCOSTEM-1 View
NCT00081913 Stem Cell Study for Patients With Heart Disease View
NCT06655662 Evaluating Safety and Efficacy of Lentiviral-transduced CD34 HSCs in Β-thalassaemia Patients View
NCT05432310 Autologous Mobilized Peripheral Blood CD34 Hematopoietic Stem and Progenitor Cells HSPC Transduced With the Elongation Factor Alpha Short Promoter EFS - Adenosine Deaminase ADA Gene EFS-ADA Lentiviral Vector for Adenosine Deaminase Severe Combined Immune Deficiency ADA SCID View
NCT06559176 A Study of the Safety and Efficacy of Prime Editing PM359 in Participants with P47phox Autosomal Recessive Chronic Granulomatous Disease CGD View
NCT05444894 EDIT-301 for Autologous Hematopoietic Stem Cell Transplant HSCT in Participants With Transfusion-Dependent Beta Thalassemia TDT View
NCT06506461 Gene Editing For Sickle Cell Disease View
NCT00003877 Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer View
NCT05477563 Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease View
NCT06565026 CS-101 in Patients With Sickle Cell Disease View
NCT06569082 CD34 Selected Stem Cell for Poor Graft Function or Graft Failure View
NCT05565105 CD34 Transplants for Leukemia and Lymphoma View
NCT06520163 Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma View
NCT00632034 Stem Cells and Tibial Fractures View
NCT01966367 CD34 Non-Malignant Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation View
NCT00692939 Autologous Stem Cell Transplantation for Crohns Disease View
NCT00006578 Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication View
NCT00019890 Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma View
NCT00742300 Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases View
NCT05662904 Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML View
NCT02589535 Circulating Stem Cells SDF-1 HIF-1 and Sepsiss Indices in Emergency Abdominal Surgical Patients View
NCT02022696 Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34 Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector View
NCT00003874 Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia View
NCT00967343 Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells ATIR in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related Haploidentical Donor View
NCT00148317 Phase II Study of Velcade Decadron and Doxil Followed by Cyclophosphamide in Multiple Myeloma View
NCT05961410 Eltrombopag for Peripheral Blood Stem Cell Harvest View
NCT01027702 Donor Lymphocyte Infusion After Alternative Donor Transplantation View
NCT01037517 Trial of an Augmented Mobilization Strategy With Plerixafor Mozobil in a Population at Risk for Poor Stem Cell Mobilization View
NCT06047886 CD34 Selection Using the Automated CliniMACS Prodigy View
NCT02140554 A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease View
NCT06287099 Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease View
NCT06286280 Removal Of CytoKines With cytoSorbenTs After Inflammatory Response Reaction During Cardiac Surgery View
NCT06287086 Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease View
NCT06308133 Biological Variables Affecting CD34 Peripheral Cells Collection Efficiency View
NCT01355913 Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes MDS Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34Cells View
NCT01351610 Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia View
NCT06363760 A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301 View
NCT06399107 Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease View
NCT06393660 Treatment Use of the CliniMACS CD34 TCR AlphaBeta for Allogenic Transplant Expanded Access Use View
NCT06414889 Protocol Title Safety and Feasibility of Autologous CD34 Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder View
NCT01438593 Study of Purified Umbilical Cord Blood CD34 Stem Cell on Chronic Ischemic Stroke View
NCT06442761 SCD Stem Cell Mobilization and Apheresis Using Motixafortide View
NCT01461837 Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease View
NCT00221182 Stem Cell Study for Patients With Heart Disease View
NCT05350163 T-cell Receptor αβ Depleted Donor Lymphocyte Infusion View
NCT02421081 Effect of Cell Surface Markers and Lymphoid Cell Distribution on the Arterial Tissue Repair ECLAR View
NCT00658385 Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor GCSF Mobilization of CD34 Hematopoietic Progenitor Cells in Patients With Betathalassemia Major View
NCT03814408 A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A View
NCT00733824 Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma View
NCT01543971 Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells PBSCs View
NCT02570542 Study of the Impact of CD34 Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma DLBCL View
NCT00730561 Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy View
NCT00004787 Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes View
NCT00311805 Autologous CD34 Stem Cell Injection for Severe Intermittent Claudication Leg Pain View
NCT02127905 Unrelated HSCT in Patients With Fanconi Anemia View
NCT00750971 Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus ASSIST View
NCT00005896 Phase I Pilot Study of CD34 Enriched Fanconis Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconis Anemia View
NCT02644759 Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus View
NCT03943238 TLI TBI ATG Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation View
NCT02158767 Access Protocol Infusion of CD34 Enriched T Cell Depleted Hematopoietic Stem Cell Grafts View
NCT00186680 CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant View
NCT01121120 Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant PBSC in Hodgkin Non-Hodgkin Lymphoma or Multiple Myeloma Patients View
NCT00038857 Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases View
NCT00001756 Study of Mast Cell Precursors View
NCT00001630 Treatment of Autoimmune Thrombocytopenia AITP View
NCT02184897 Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization View
NCT01050946 Hematopoietic Stem Cell Transplantation HSCT Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit View
NCT01156350 Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma View
NCT01182233 Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation View
NCT01206075 Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major View
NCT01249287 FMRI in Monitoring Intracerebral Stem Cell Implantation for Chronic Stroke Patients View
NCT01517035 Improving Blood Stem Cell Collection and Transplant Procedures View
NCT02248532 Repetitive Intramyocardial CD34 Cell Therapy in Dilated Cardiomyopathy REMEDIUM View
NCT01380990 Lentiviral LV Gene Therapy for Adenosine Deaminase ADA Deficiency View
NCT05510089 EtoposideCytarabinePEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies View
NCT00001405 Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells Mononuclear Cells and Granulocytes View
NCT00017654 Study of Allogeneic Bone Marrow and T-Cell Depleted CD34 Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia View
NCT00271089 Blood Cell Collection for Future Use in Individuals With Fanconi Anemia View
NCT00306332 T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation View
NCT00319657 Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs View
NCT00322842 Treatment With AMD3100 Plerixafor in Non-Hodgkins Lymphoma and Multiple Myeloma Patients View
NCT00003056 Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation View
NCT00040482 High Dose ChemoRadiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis View
NCT00067639 Pegfilgrastim Neulasta for Stem Cell Mobilization in Patients With Multiple Myeloma View
NCT00103662 Mobilization of Stem Cells With AMD3100 Plerixafor in Multiple Myeloma Patients View
NCT00162929 Her-2Neu in Patients With Metastatic Breast Cancer AdHERe View
NCT00186797 Purified CD34 Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia View
NCT00221143 Stem Cell Study for Patients With Leg UlcerGangrene View
NCT00245115 Ex Vivo Expansion of Mafosfamide Purged CD34 Cells in Patients With Acute Leukemia View
NCT00288626 High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis HALT MS Study View
NCT00300053 ACT34-CMI -- Adult Autologous CD34 Cells View
NCT00376480 Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant View
NCT00395967 AMD3100 Plerixafor in Multiple Myeloma MM or Non-Hodgkins Lymphoma NHL Patients Predicted to be Unable to Mobilize With G-CSF Alone View
NCT00396331 AMD3100 Plerixafor With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell HSC CollectionAttempts View
NCT00396266 AMD3100 Plerixafor Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF View
NCT00450983 Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation Thiotepa Fludarabine and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases View
NCT00479115 Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 View
NCT00587054 Trial of Allogeneic Stem Cell Transplants From HLA Compatible Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders View
NCT00598481 ADA Gene Transfer Into Hematopoietic StemProgenitor Cells for the Treatment of ADA-SCID View
NCT00629018 Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy View
NCT00638820 Reduced Intensity AlloTransplant For Osteopetrosis View
NCT00671242 Angiogenesis With Positron Emission Tomography PET Tracer Uptake View
NCT00747708 Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure View
NCT00758992 Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages View
NCT00788827 Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant View
NCT00901225 Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant View
NCT02438904 Compassionate Access of the Miltenyi Device for CD34 Cell Selection View
NCT02500550 Safety and Efficacy of Two Doses of ATIR101 a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor View
NCT02559791 Anti-Interleukin-5 IL5 Monoclonal Antibody MAb in Prednisone-dependent Eosinophilic Asthma View
NCT02572596 Comparing Intermediate-dose CTX G-CSF Plus or Not rhTPO for PB CD34 Cells Mobilization in MM Patients View
NCT02639559 Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies View
NCT02678533 Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor View
NCT02675959 Myeloablative Conditioning Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease View
NCT02757911 Gene Therapy for X-linked Chronic Granulomatous Disease View
NCT02806791 Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34 Cluster of Differentiation 34 and on the Kinetic Engraftment View
NCT02866331 G-CSF and Autologous Cord Blood Infusion in Cerebral Palsy View
NCT02906202 A Study Evaluating the Efficacy and Safety of the LentiGlobin BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia Who do Not Have a β0β0 Genotype View
NCT02964585 Role of Canagliflozin on CD34 Cells in Patients With Type 2 Diabetes View
NCT03182426 Stem Cell Mobilization Plerixafor and Immunologic Reset in Type 1 Diabetes T1DM View
NCT03233659 Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation View
NCT03292445 Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation View
NCT03423706 Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation View
NCT03473457 CAR-T Cells Therapy in RelapsedRefractory Acute Myeloid Leukemia View
NCT03538899 Autologous Gene Therapy for Artemis-Deficient SCID View
NCT03626285 Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders View
NCT03655678 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia View
NCT03756675 Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia View
NCT03765632 Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID View
NCT03812263 A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I View
NCT03875495 A Phase III Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy TEM-MM View
NCT03897361 Stem Cell Gene Therapy for Cystinosis View
NCT03903055 Study on High-risk MDS Patients Based on RNA-seq Technology View
NCT04098393 Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation View
NCT04113317 Granulocyte-Colony Stimulating Factor G-CSF as Optimizing Therapy for Pediatric Liver Transplantation View
NCT04186052 Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive rr Multiple Myeloma View